Literature DB >> 7564488

Pulmonary function survey in spinal cord injury: influences of smoking and level and completeness of injury.

P L Almenoff1, A M Spungen, M Lesser, W A Bauman.   

Abstract

Spirometry was performed on 165 subjects with spinal cord injury (84 with quadriplegia and 81 with paraplegia). Subjects were characterized by level of lesion as: high quadriplegia (HQ, C4 and above not requiring mechanical ventilation), low quadriplegia (LQ, C5-8), high paraplegia (HP, T1-7), and low paraplegia (LP, T8-L3). Thirty-nine subjects had complete motor lesions, and 126 had incomplete motor lesions. Nonsmokers (54 with quadriplegia and 53 with paraplegia) were defined as those who had never smoked or those who had stopped smoking for 1 year. Current smokers (28 with quadriplegia and 28 with paraplegia) were defined as those who currently smoked cigarettes, cigars, and/or pipe or those who had quit for < or = 1 year. We found by linear regression analysis that forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), peak expiratory flow (PEF), and maximal voluntary ventilation (MVV) were inversely correlated with the level of injury (i.e., the higher the level of injury, the lower the parameter). In the HQ group, those with complete injury had significantly lower pulmonary function parameters than those with incomplete lesions. In contrast, there were no significant differences in pulmonary function parameters between complete and incomplete lesions in subjects in the LQ, HP, and LP groups. In the LQ, HP, and LP groups, the FEV1 and PEF were significantly lower in smokers than in nonsmokers. Thus, this study demonstrates the effects of completeness of injury and smoking on pulmonary function in a large group of subjects with spinal cord injury.

Entities:  

Mesh:

Year:  1995        PMID: 7564488     DOI: 10.1007/BF00176893

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  30 in total

1.  Respiratory function in patients with spinal cord injuries: effects of posture.

Authors:  C F Chen; I N Lien; M C Wu
Journal:  Paraplegia       Date:  1990-02

2.  IMPAIRMENT OF RESPIRATION AFTER SPINAL CORD INJURY.

Authors:  A HAAS; E W LOWMAN; E H BERGOFSKY
Journal:  Arch Phys Med Rehabil       Date:  1965-06       Impact factor: 3.966

3.  Effects of respiratory muscle paralysis in tetraplegic and paraplegic patients.

Authors:  A R Fugl-Meyer
Journal:  Scand J Rehabil Med       Date:  1971

4.  Pulmonary function, ventilatory control, and respiratory complications in quadriplegic subjects.

Authors:  A C McKinley; J H Auchincloss; R Gilbert; J J Nicholas
Journal:  Am Rev Respir Dis       Date:  1969-10

Review 5.  Neural control of human airways in health and disease.

Authors:  P J Barnes
Journal:  Am Rev Respir Dis       Date:  1986-12

6.  Lung volumes in tetraplegic patients according to cervical spinal cord injury level.

Authors:  A Anke; A K Aksnes; J K Stanghelle; N Hjeltnes
Journal:  Scand J Rehabil Med       Date:  1993-06

7.  Pulmonary function in acute cervical cord injury.

Authors:  J R Ledsome; J M Sharp
Journal:  Am Rev Respir Dis       Date:  1981-07

8.  Pulmonary complications of acute spinal cord injuries.

Authors:  H D Reines; R C Harris
Journal:  Neurosurgery       Date:  1987-08       Impact factor: 4.654

9.  Activation of a novel medullary pathway elicits a vagal, cholinergic bronchoconstriction in guinea-pigs.

Authors:  J A Hey; M del Prado; R W Chapman
Journal:  Pulm Pharmacol       Date:  1990

10.  Pulmonary function in tetraplegic and paraplegic patients.

Authors:  K Kokkola; K Möller; T Lehtonen
Journal:  Ann Clin Res       Date:  1975-04
View more
  14 in total

1.  Respiratory complications of spinal cord injury.

Authors:  Christopher P Cardozo
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

2.  A latent variable structural path model of health behaviors after spinal cord injury.

Authors:  James S Krause; John J McArdle; Elisabeth Pickelsimer; Karla S Reed
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

3.  Methods used to quit smoking by people with physical disabilities.

Authors:  Belinda Borrelli; Andrew M Busch; David R M Trotter
Journal:  Rehabil Psychol       Date:  2013-02-25

4.  Effects of Respiratory Training on Heart Rate Variability and Baroreflex Sensitivity in Individuals With Chronic Spinal Cord Injury.

Authors:  Bonnie E Legg Ditterline; Sevda C Aslan; David C Randall; Susan J Harkema; Camilo Castillo; Alexander V Ovechkin
Journal:  Arch Phys Med Rehabil       Date:  2017-08-09       Impact factor: 3.966

5.  Determinants of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC in chronic spinal cord injury.

Authors:  Nitin B Jain; Robert Brown; Carlos G Tun; David Gagnon; Eric Garshick
Journal:  Arch Phys Med Rehabil       Date:  2006-10       Impact factor: 3.966

6.  Respiratory dysfunction and management in spinal cord injury.

Authors:  Robert Brown; Anthony F DiMarco; Jeannette D Hoit; Eric Garshick
Journal:  Respir Care       Date:  2006-08       Impact factor: 2.258

7.  Longitudinal change in FEV1 and FVC in chronic spinal cord injury.

Authors:  Kelly L Stolzmann; David R Gagnon; Robert Brown; Carlos G Tun; Eric Garshick
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

8.  Determinants of lung volumes in chronic spinal cord injury.

Authors:  Evan L Stepp; Robert Brown; Carlos G Tun; David R Gagnon; Nitin B Jain; Eric Garshick
Journal:  Arch Phys Med Rehabil       Date:  2008-08       Impact factor: 3.966

9.  A center's experience: pulmonary function in spinal cord injury.

Authors:  Gregory J Schilero; Miroslav Radulovic; Jill M Wecht; Ann M Spungen; William A Bauman; Marvin Lesser
Journal:  Lung       Date:  2014-04-11       Impact factor: 2.584

10.  Cigarette smoking among adults with mobility impairments: a US population-based survey.

Authors:  Belinda Borrelli; Andrew Busch; Shira Dunsiger
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.